Phesgo and Tecentriq Performance and Approvals slide image

Phesgo and Tecentriq Performance and Approvals

Corporate Executive Committee Since April 2023 Pharma Division Teresa Graham Pharma CEO* Levi Garraway Head of Pharma Dev / CMO* Hans Clevers Head of PRED Aviv Regev Head of GRED Thomas Schinecker CEO Group Diagnostics Division Group Functions Matt Sause Diagnostics CEO Alan Hippe CFO/CIO Cris Wilbur Chlef People Officer Claudia Boeckstiegel General Counsel Barbara Schaedler Head of Group Comms James Sabry Head of Partnering *Co-chair late stage pipeline committee (LSPC); PRED=Pharma Research & Early Development; gRED=Genentech Research & Early Development Silke Hoernstein Head of Strategy & Sustainability Roche 13
View entire presentation